NL
REGN icon

NWAM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

NWAM LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
1,680
-237
-12% -$161K 0.05% 320
2026
Q1 		$1.48M Buy
1,917
+195
+11% +$149K 0.09% 221
2025
Q4 		$1.31M Buy
1,722
+129
+8% +$87.6K 0.07% 235
2025
Q3 		$918K Buy
1,593
+38
+2% +$21.5K 0.05% 296
2025
Q2 		$848K Buy
1,555
+16
+1% +$8.93K 0.05% 297
2025
Q1 		$976K Sell
1,539
-130
-8% -$89.4K 0.08% 212
2024
Q4 		$1.19M Sell
1,669
-89
-5% -$74.7K 0.07% 239
2024
Q3 		$1.85M Hold
1,758
– – 0.11% 180
2024
Q2 		$1.85M Buy
1,758
+125
+8% +$121K 0.54% 34
2024
Q1 		$1.58M Sell
1,633
-6
-0.4% -$5.71K 0.13% 160
2023
Q4 		$1.44M Sell
1,639
-135
-8% -$111K 0.12% 179
2023
Q3 		$1.46M Buy
1,774
+8
+0.5% +$6.29K 0.15% 141
2023
Q2 		$1.27M Buy
1,766
+141
+9% +$109K 0.1% 192
2023
Q1 		$1.34M Sell
1,625
-112
-6% -$84.5K 0.14% 156
2022
Q4 		$1.25M Buy
1,737
+107
+7% +$79K 0.11% 184
2022
Q3 		$1.12M Buy
1,630
+17
+1% +$10.7K 0.11% 183
2022
Q2 		$961K Sell
1,613
-402
-20% -$261K 0.09% 208
2022
Q1 		$1.41M Buy
2,015
+26
+1% +$16.4K 0.11% 186
2021
Q4 		$1.26M Buy
1,989
+1,141
+135% +$702K 0.1% 205
2021
Q3 		$513K Buy
+848
New +$526K 0.05% 319

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NWAM LLC's REGN Position: Q2 2026 in Review

NWAM LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, selling an estimated $161K and leaving 1,680 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #320.

NWAM LLC first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.85M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NWAM LLC held 1,680 shares of Regeneron Pharmaceuticals worth $1.05M as of Q2 2026.
  • NWAM LLC sold 237 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $161K.
  • Regeneron Pharmaceuticals made up 0.05% of NWAM LLC's portfolio in Q2 2026, its #320 holding.
  • NWAM LLC first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • NWAM LLC's Regeneron Pharmaceuticals position peaked at $1.85M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.